At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 379 enrolled
Drug / intervention
Abametapir Lotion 0.74% w/w +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Multicenter, Vehicle-Controlled Study of the Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
In Brief
A Phase 3 clinical trial evaluating Abametapir Lotion 0.74% w/w and Vehicle Lotion for Head Lice Infestation. Completed, enrolled 379 participants across 7 sites.
Detailed Summary
The purpose of the study was to assess the efficacy, safety and tolerability of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at home.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHead Lice Infestation
CountriesUnited States
CollaboratorsAccelovance, Syneos Health
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2014
First PostedFeb 2014
Primary CompletionJul 2014
Study CompletionAug 2014
TodayJul 2026
First PostedFeb 12, 2014
Enrollment StartFeb 1, 2014
Primary CompletionJul 1, 2014
Study CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.4 years ago
Interventions
Abametapir Lotion 0.74% w/wdrug
Abametapir Lotion 0.74% was dispensed to subjects on Day 0 for self-administration at home on the same day.
Vehicle Lotiondrug
Vehicle Lotion was dispensed to subjects on Day 0 for self-administration at home on the same day.